vs

Side-by-side financial comparison of Baxter International (BAX) and ICON PLC (ICLR). Click either name above to swap in a different company.

Baxter International is the larger business by last-quarter revenue ($2.7B vs $2.0B, roughly 1.3× ICON PLC). ICON PLC runs the higher net margin — 0.1% vs -0.6%, a 0.7% gap on every dollar of revenue. On growth, Baxter International posted the faster year-over-year revenue change (3.0% vs 0.6%). ICON PLC produced more free cash flow last quarter ($333.9M vs $76.0M). Over the past eight quarters, ICON PLC's revenue compounded faster (0.6% CAGR vs -15.8%).

Baxter International Inc. is an American multinational healthcare company with headquarters in Deerfield, Illinois.

ICON plc is an Irish headquartered multinational healthcare intelligence and clinical research organisation. As of February 2025 had approximately 41,900 employees in 55 countries.

BAX vs ICLR — Head-to-Head

Bigger by revenue
BAX
BAX
1.3× larger
BAX
$2.7B
$2.0B
ICLR
Growing faster (revenue YoY)
BAX
BAX
+2.4% gap
BAX
3.0%
0.6%
ICLR
Higher net margin
ICLR
ICLR
0.7% more per $
ICLR
0.1%
-0.6%
BAX
More free cash flow
ICLR
ICLR
$257.9M more FCF
ICLR
$333.9M
$76.0M
BAX
Faster 2-yr revenue CAGR
ICLR
ICLR
Annualised
ICLR
0.6%
-15.8%
BAX

Income Statement — Q1 FY2026 vs Q3 FY2025

Metric
BAX
BAX
ICLR
ICLR
Revenue
$2.7B
$2.0B
Net Profit
$-15.0M
$2.4M
Gross Margin
33.0%
Operating Margin
2.4%
4.2%
Net Margin
-0.6%
0.1%
Revenue YoY
3.0%
0.6%
Net Profit YoY
-98.8%
EPS (diluted)
$-0.03
$0.03

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BAX
BAX
ICLR
ICLR
Q1 26
$2.7B
Q4 25
$3.0B
Q3 25
$2.8B
$2.0B
Q2 25
$2.8B
$2.0B
Q1 25
$2.6B
$2.0B
Q4 24
$533.0M
Q3 24
$2.7B
$2.0B
Q2 24
$3.8B
$2.1B
Net Profit
BAX
BAX
ICLR
ICLR
Q1 26
$-15.0M
Q4 25
$-1.1B
Q3 25
$-46.0M
$2.4M
Q2 25
$91.0M
$183.0M
Q1 25
$126.0M
$154.2M
Q4 24
$-512.0M
Q3 24
$140.0M
$197.1M
Q2 24
$-314.0M
$146.9M
Gross Margin
BAX
BAX
ICLR
ICLR
Q1 26
33.0%
Q4 25
19.4%
Q3 25
33.5%
Q2 25
35.3%
Q1 25
32.8%
Q4 24
25.0%
Q3 24
38.3%
Q2 24
37.5%
Operating Margin
BAX
BAX
ICLR
ICLR
Q1 26
2.4%
Q4 25
-24.5%
Q3 25
6.1%
4.2%
Q2 25
6.8%
10.4%
Q1 25
2.2%
11.0%
Q4 24
-25.5%
Q3 24
5.7%
14.1%
Q2 24
-5.0%
10.8%
Net Margin
BAX
BAX
ICLR
ICLR
Q1 26
-0.6%
Q4 25
-37.9%
Q3 25
-1.6%
0.1%
Q2 25
3.2%
9.1%
Q1 25
4.8%
7.7%
Q4 24
-96.1%
Q3 24
5.2%
9.7%
Q2 24
-8.2%
6.9%
EPS (diluted)
BAX
BAX
ICLR
ICLR
Q1 26
$-0.03
Q4 25
$-2.21
Q3 25
$-0.09
$0.03
Q2 25
$0.18
$2.30
Q1 25
$0.25
$1.90
Q4 24
$-0.99
Q3 24
$0.27
$2.36
Q2 24
$-0.62
$1.76

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BAX
BAX
ICLR
ICLR
Cash + ST InvestmentsLiquidity on hand
$468.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$9.3B
Total Assets
$16.5B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BAX
BAX
ICLR
ICLR
Q1 26
Q4 25
$2.0B
Q3 25
$1.7B
$468.9M
Q2 25
$1.7B
$390.4M
Q1 25
$2.3B
$526.7M
Q4 24
$1.8B
Q3 24
$1.4B
$695.5M
Q2 24
$2.1B
$506.6M
Total Debt
BAX
BAX
ICLR
ICLR
Q1 26
Q4 25
$9.5B
Q3 25
Q2 25
Q1 25
Q4 24
$10.4B
Q3 24
$10.4B
Q2 24
$10.4B
Stockholders' Equity
BAX
BAX
ICLR
ICLR
Q1 26
Q4 25
$6.1B
Q3 25
$7.2B
$9.3B
Q2 25
$7.3B
$9.6B
Q1 25
$7.1B
$9.5B
Q4 24
$7.0B
Q3 24
$7.9B
$9.8B
Q2 24
$7.6B
$9.6B
Total Assets
BAX
BAX
ICLR
ICLR
Q1 26
Q4 25
$20.1B
Q3 25
$21.1B
$16.5B
Q2 25
$21.0B
$16.6B
Q1 25
$21.3B
$16.7B
Q4 24
$25.8B
Q3 24
$26.7B
$17.2B
Q2 24
$26.3B
$17.0B
Debt / Equity
BAX
BAX
ICLR
ICLR
Q1 26
Q4 25
1.55×
Q3 25
Q2 25
Q1 25
Q4 24
1.49×
Q3 24
1.33×
Q2 24
1.37×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BAX
BAX
ICLR
ICLR
Operating Cash FlowLast quarter
$387.6M
Free Cash FlowOCF − Capex
$76.0M
$333.9M
FCF MarginFCF / Revenue
2.8%
16.3%
Capex IntensityCapex / Revenue
5.1%
2.6%
Cash ConversionOCF / Net Profit
164.59×
TTM Free Cash FlowTrailing 4 quarters
$1.0B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BAX
BAX
ICLR
ICLR
Q1 26
Q4 25
$584.0M
Q3 25
$237.0M
$387.6M
Q2 25
$217.0M
$146.2M
Q1 25
$-193.0M
$268.2M
Q4 24
$488.0M
Q3 24
$253.0M
$402.7M
Q2 24
$115.0M
$218.6M
Free Cash Flow
BAX
BAX
ICLR
ICLR
Q1 26
$76.0M
Q4 25
Q3 25
$333.9M
Q2 25
$113.9M
Q1 25
$239.3M
Q4 24
Q3 24
$359.3M
Q2 24
$182.3M
FCF Margin
BAX
BAX
ICLR
ICLR
Q1 26
2.8%
Q4 25
Q3 25
16.3%
Q2 25
5.6%
Q1 25
12.0%
Q4 24
Q3 24
17.7%
Q2 24
8.6%
Capex Intensity
BAX
BAX
ICLR
ICLR
Q1 26
5.1%
Q4 25
Q3 25
2.6%
Q2 25
1.6%
Q1 25
1.4%
Q4 24
Q3 24
2.1%
Q2 24
1.7%
Cash Conversion
BAX
BAX
ICLR
ICLR
Q1 26
Q4 25
Q3 25
164.59×
Q2 25
2.38×
0.80×
Q1 25
-1.53×
1.74×
Q4 24
Q3 24
1.81×
2.04×
Q2 24
1.49×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BAX
BAX

Segment breakdown not available.

ICLR
ICLR

Other Customers$681.3M33%
Clients1125$549.4M27%
Clients15$503.3M25%
Clients610$308.8M15%

Related Comparisons